Loading…
Genomic Valley Biotech (BSE 539206)₹50.13−9.72%Biotechnology
At the end of the Jun 2026 quarter, Genomic Valley Biotech's shareholders were: promoters 46.00%, public 54.00%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 2,449 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.26% | 64.98% | 64.14% | 64.08% | 54.61% | 46.77% | 46.72% | 46.66% | 46.66% | 46.00% | 46.00% | 46.00% |
| Public | 33.74% | 35.02% | 35.86% | 35.92% | 45.39% | 53.23% | 53.28% | 53.34% | 53.34% | 54.00% | 54.00% | 54.00% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 592 | 1,015 | 1,335 | 1,541 | 2,129 | 2,498 | 2,505 | 2,461 | 2,460 | 2,523 | 2,482 | 2,449 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Yogesh Agrawal | Promoter | 46.05% | 0.00 |
| Deepti Aggarwal | Public | 10.98% | 0.00 |
| Amar Aggarwal | Public | 9.10% | 0.00 |
| Vikram Ashokkumar Jain | Public | 5.54% | 0.00 |
| Wasp Tradmart Private Limited | Public | 1.20% | −0.06 |
| Ojaswini Avantika | Promoter | 0.00% | 0.00 |
| Parul Agrawal | Promoter | 0.00% | 0.00 |
Promoters held 46.00% of Genomic Valley Biotech at the end of the Jun 2026 quarter, down 0.66 percentage points from 46.66% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Genomic Valley Biotech had 2,449 shareholders at the end of the Jun 2026 quarter, against 2,461 a year earlier.
Deepti Aggarwal (Public) held 10.98% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.